About
Peptide-based Therapies for cancers
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyNJ, NY, PA
Team (16)
Abi Vainstein-Haras
Abi Vainstein-Haras, M.D.
Sapience Therapeutics
team_member
Andrew B
Andrew B. Lassman, M.D.
Sapience Therapeutics
team_member
Augustine Bourne
Augustine Bourne
Sapience Therapeutics
team_member
Barry Kappel
Barry Kappel, Ph.D., M.B.A.
Sapience Therapeutics
team_member
Christian S
Christian S. Schade
Sapience Therapeutics
team_member
David Scheinberg
David Scheinberg, M.D., Ph.D.
Sapience Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
255
By Phase
PHASE1: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05848739Lead Sponsor
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
PHASE1Recruiting
130 participants
Started: Jun 5, 2023 · Completed: May 31, 2027
NCT04478279Lead Sponsor
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
125 participants
Started: Jul 1, 2020 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Tarrytown, NY, United States
Map
Loading map...